180 THERAPEUTICS

Welcome to the Brand page for “180 THERAPEUTICS”, which is offered here for Analgesic preparations; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of dupuytren's disease; pharmaceutical preparations for the treatment of frozen shoulder; pharmaceutical preparations for the treatment of post-operative delirium; pharmaceutical preparations for the treatment of post-operative cognitive deficit; pharmaceutical preparations for the treatment of post-operative cognitive decline; pharmaceutical preparations for the treatment of non-alcoholic steatohepatitis; pharmaceutical preparations for the treatment of fibrosis; pharmaceutical preparations for the treatment of liver fibrosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of ulcerative colitis; pharmaceutical preparations for the treatment of anxiety; pharmaceutical preparations for the treatment of type 1 diabetes; pharmaceutical preparations for the treatment of type 2 diabetes; pharmaceutical preparations for inhibition of tumor necrosis factor (tnf); pharmaceutical preparations for interacting with nicotine receptors; pharmaceutical preparations for synthetically simulating non-psychoactive effects of cannabidiol (cbd); pharmaceutical preparations for liver regeneration; pharmaceutical preparations for regenerative therapy; pharmaceutical preparations for acting as an alpha-7nachr agonist;development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields; scientific research for medical purposes in the field of inflammatory diseases; scientific research for medical purposes in the field of treatment of inflammation; scientific research for medical purposes in the field of dupuytren's disease; scientific research for medical purposes in the field of frozen shoulder; scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline; scientific research for medical purposes in the field of non-alcoholic steatohepatitis; scientific research for medical purposes in the field of fibrosis; scientific research for medical purposes in the field of liver fibrosis; scientific research for medical purposes in the field of arthritis; scientific research for medical purposes in the field of pain treatment; scientific research for medical purposes in the field of ulcerative colitis; scientific research for medical purposes in the field of treatment of anxiety; scientific research for medical purposes in the field of inhibition of tumor necrosis factor (tnf) and anti-tnf pharmaceuticals; scientific research for medical purposes in the field of interactions with nicotine receptors; scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (cbd); scientific research for medical purposes in the field of synthetic cannabidiol (cbd) analogs; scientific research for medical purposes in the field of type 1 diabetes; scientific research for medical purposes in the field of type 2 diabetes; scientific research for medical purposes in the field of liver regeneration; scientific research for medical purposes in the field of regenerative therapy; scientific research for medical purposes in the field of alpha-7nachr agonists;.

Its status is currently believed to be active. Its class is unavailable. “180 THERAPEUTICS” is believed to be currently owned by “180 Life Sciences Corp.”